|
Volumn 21, Issue 5, 2008, Pages 508-509
|
Rituximab therapy for cytomegalovirus-associated auto-immune hemolytic anemia in a liver-transplant recipient
a a a a
a
CHU RANGUEIL
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPITOPE;
ERYTHROCYTE ANTIGEN;
GANCICLOVIR;
HEMOGLOBIN;
IMMUNOGLOBULIN;
LACTATE DEHYDROGENASE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PREDNISOLONE;
PREDNISONE;
RITUXIMAB;
TACROLIMUS;
VALGANCICLOVIR;
VIRUS DNA;
AUTOIMMUNE HEMOLYTIC ANEMIA;
BLOOD TRANSFUSION;
CASE REPORT;
CLINICAL FEATURE;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
GRAFT RECIPIENT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LETTER;
LIVER TRANSPLANTATION;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
RETICULOCYTE COUNT;
TREATMENT OUTCOME;
ADULT;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
ANTIBODIES, MONOCLONAL;
CYTOMEGALOVIRUS INFECTIONS;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
|
EID: 41749085252
PISSN: 09340874
EISSN: 14322277
Source Type: Journal
DOI: 10.1111/j.1432-2277.2008.00650.x Document Type: Letter |
Times cited : (4)
|
References (6)
|